Hereditary cancer syndromes highlight the importance of genetic counseling and testing in cancer prevention and management. Syndromes such as those associated with BRCA1, BRCA2, or Lynch syndrome increase susceptibility to cancers like breast, ovarian, and colorectal. Genetic testing identifies individuals carrying high-risk mutations, allowing for early interventions and personalized management plans. Genetic counselors play a critical role in guiding patients through this process, interpreting test results, and discussing options such as enhanced surveillance, risk-reducing surgeries, or chemoprevention. Beyond medical implications, counseling addresses the emotional impact of genetic findings on individuals and their families. Advances in testing technology, including multi-gene panels, enable the identification of broader genetic risks. By promoting early detection and preventive measures, genetic counseling and testing empower individuals to make informed decisions, reducing the burden of hereditary cancers and improving long-term outcomes.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States